Phenobarbitone of jaundice in haemolytic patients.
D000293:Adolescent; D000328:Adult; D000373:Agglutinins; D000743:Anemia, Hemolytic / Q000188:drug therapy*; D001323:Autoantibodies; D001663:Bilirubin / Q000378:metabolism; D003080:Cold Temperature; D005260:Female; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000188:drug therapy; D006602:Hexosyltransferases / Q000378:metabolism; D006801:Humans; D006932:Hyperbilirubinemia / Q000188:drug therapy; D007565:Jaundice / Q000188:drug therapy*; D008099:Liver / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D010634:Phenobarbital / Q000627:therapeutic use*; D013103:Spherocytosis, Hereditary / Q000188:drug therapy; D013789:Thalassemia / Q000188:drug therapy; D014316:Tritium
D000373:Agglutinins; D001323:Autoantibodies; D014316:Tritium; D006602:Hexosyltransferases; D001663:Bilirubin; D010634:Phenobarbital